NASDAQ:ACLX - Nasdaq - US03940C1009 - Common Stock - Currency: USD
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 107.94M | 110.32M | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 245.51M | 200.20M | 191.26M | 65.02M | 32.10M | |||
Research and Development | 157.09M | 133.85M | 149.56M | 46.88M | 25.06M | |||
Selling, General, and Administrative Expenses | 88.41M | 66.35M | 41.70M | 18.14M | 7.04M | |||
Operating Income | -137.57M | -89.88M | -191.26M | -65.02M | -32.10M | |||
Interest Income/Expense | 32.29M | 19.85M | 2.58M | N/A | N/A | |||
Other Income/Expense | N/A | N/A | N/A | 50.00K | 0.00 | |||
Income Before Taxes | -105.28M | -70.03M | -188.68M | -64.97M | -32.10M | |||
Income Tax | 2.07M | 663.00K | N/A | N/A | N/A | |||
Net Income | -107.35M | -70.69M | -188.68M | -64.97M | -32.10M | |||
EBITDA | -132.38M | -87.84M | -189.94M | -63.98M | -31.47M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.00 | -1.47 | -5.19 | -1.87 | -0.92 | |||
Non GAAP EPS | N/A | -1.47 | -5.32 | N/A | N/A | |||
Statistics | ||||||||
Profit Margin | -99.46% | -64.08% | N/A | N/A | N/A | |||
Operating Profit Margin | -127.46% | -81.47% | N/A | N/A | N/A |
All data in USD